Tallaght Hospital has become the first in Ireland to pilot a new minimally invasive technology to treat Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate gland. Led by Consultant Urology Surgeon, Mr. Rustom Manecksha, five patients have undergone a new minimally invasive procedure called Prostate Urethral Lift (PUL) using the UroLift® System. BOH affects one in four men over the age of 40 and, although it is part of the natural ageing process, it can result in an obstruction that could causes lower urinary tract symptoms.
Patients report a range of complaints including difficulty starting a urine stream, a weak or interrupted urine stream, frequent need to urinate both during the day and at night, or urinary retention. Benefits of this procedure include reduced risk to sexual function, quicker recovery times, and no interference with future procedures for the same condition, should the need arise. It is also beneficial that the treatment can be completed under local rather than general anaesthetic, with reduces the typical length of stay required in hospital afterwards.
The process is less invasive, using implants to retract obstructing lateral lobes of the prostate gland and expanding the urethral lumen before clearing the obstruction and relieving symptoms without the need to cut, heat or remove prostate tissue. Mr Manecksha stated: “The early indications are that this new technology will benefit both patients and hospitals so I am very proud that Tallaght Hospital is the first public facility in Ireland to pilot the procedure.”
All five patients involved in the trial were happy that they could go home on the same day of their procedure and reported feeling ‘comfortable’ while it was being carried out.